GB1511645A - Sickle cell anaemia treatment - Google Patents
Sickle cell anaemia treatmentInfo
- Publication number
- GB1511645A GB1511645A GB15999/74A GB1599974A GB1511645A GB 1511645 A GB1511645 A GB 1511645A GB 15999/74 A GB15999/74 A GB 15999/74A GB 1599974 A GB1599974 A GB 1599974A GB 1511645 A GB1511645 A GB 1511645A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sickle cell
- cell anaemia
- treatment
- methyl
- anaemia treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1511645 Compositions for use in sickle cell anaemia treatment UNIVERSITY OF IFE 7 May 1975 [31 May 1974] 15999/74 Heading A5B Pharmaceutical compositions, for use in treating sickle cell anaemia, comprise a pharmaceutically acceptable vehicle and at least one antisickling agent of the formula: where R<SP>1</SP>, R<SP>3</SP> and R<SP>4</SP> are the same or different and represent hydrogen, methyl, ethyl or acetyl groups; R<SP>2</SP> is a hydrogen, methyl or ethyl group and m, n and p represent zero or one, except that m and n are not simultaneously zero.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB15999/74A GB1511645A (en) | 1974-05-31 | 1974-05-31 | Sickle cell anaemia treatment |
DE19752523108 DE2523108A1 (en) | 1974-05-31 | 1975-05-24 | Remedies for sickle cell anemia |
ZA00753364A ZA753364B (en) | 1974-05-31 | 1975-05-26 | Sickle cell anaemia treatment |
FR7516781A FR2272647B1 (en) | 1974-05-31 | 1975-05-29 | |
NL7506384A NL7506384A (en) | 1974-05-31 | 1975-05-29 | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS FOR THE CONTROL OF SICKLE CELL ANAEMIA. |
MW32/75A MW3275A1 (en) | 1974-05-31 | 1975-05-29 | Sickle cell anaemia treatment |
BE156931A BE829756A (en) | 1974-05-31 | 1975-05-30 | TREATMENT OF FALCIFORM HEMATIES ANEMIA |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB15999/74A GB1511645A (en) | 1974-05-31 | 1974-05-31 | Sickle cell anaemia treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1511645A true GB1511645A (en) | 1978-05-24 |
Family
ID=10069370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB15999/74A Expired GB1511645A (en) | 1974-05-31 | 1974-05-31 | Sickle cell anaemia treatment |
Country Status (7)
Country | Link |
---|---|
BE (1) | BE829756A (en) |
DE (1) | DE2523108A1 (en) |
FR (1) | FR2272647B1 (en) |
GB (1) | GB1511645A (en) |
MW (1) | MW3275A1 (en) |
NL (1) | NL7506384A (en) |
ZA (1) | ZA753364B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4410537A (en) | 1979-06-29 | 1983-10-18 | Burroughts Wellcome Co. | Pharmaceutical ethers |
US5635533A (en) * | 1991-10-21 | 1997-06-03 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for inducing differentiation of a cell using phenyacetic acid and derivatives |
US5843994A (en) * | 1991-10-21 | 1998-12-01 | The United States Of America As Represeneted By The Department Of Health And Human Services | Compositions and methods for treating and preventing pathologies including cancer |
US5877213A (en) * | 1991-10-21 | 1999-03-02 | The United States Of America As Represented By The Department Of Health And Human Services | Compositions and methods for therapy and prevention of cancer, AIDS, and anemia |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2550785B1 (en) * | 1983-08-18 | 1985-12-06 | Sanofi Sa | NOVEL COMPOSITIONS WITH ANTIMICROBIAL ACTIVITY CONTAINING BENZOIC ACID DERIVATIVES, THEIR PREPARATION METHOD, THEIR USE AS DISINFECTANT OR PRESERVATIVE DRUGS |
US5003055A (en) * | 1987-09-25 | 1991-03-26 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Anthracycline derivatives having inhibitory activity against reverse transcriptase of human immunodeficiency virus |
EP0567613B1 (en) * | 1991-10-21 | 2002-02-20 | The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services | Compositions for therapy and prevention of cancer |
-
1974
- 1974-05-31 GB GB15999/74A patent/GB1511645A/en not_active Expired
-
1975
- 1975-05-24 DE DE19752523108 patent/DE2523108A1/en not_active Withdrawn
- 1975-05-26 ZA ZA00753364A patent/ZA753364B/en unknown
- 1975-05-29 FR FR7516781A patent/FR2272647B1/fr not_active Expired
- 1975-05-29 MW MW32/75A patent/MW3275A1/en unknown
- 1975-05-29 NL NL7506384A patent/NL7506384A/en not_active Application Discontinuation
- 1975-05-30 BE BE156931A patent/BE829756A/en unknown
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4410537A (en) | 1979-06-29 | 1983-10-18 | Burroughts Wellcome Co. | Pharmaceutical ethers |
US5635533A (en) * | 1991-10-21 | 1997-06-03 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for inducing differentiation of a cell using phenyacetic acid and derivatives |
US5635532A (en) * | 1991-10-21 | 1997-06-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia |
US5654333A (en) * | 1991-10-21 | 1997-08-05 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for prevention of cancer using phenylacetic acids and derivatives thereof |
US5661179A (en) * | 1991-10-21 | 1997-08-26 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for treating neoplastic conditions using phenylacetic acid and derivatives thereof |
US5708025A (en) * | 1991-10-21 | 1998-01-13 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for promoting wound healing |
US5712307A (en) * | 1991-10-21 | 1998-01-27 | The United States Of America As Represented By The Department Of Health And Human Services | Methods of inducing the production of hemoglobin and treating pathologies associated with abnormal hemoglobin activity using phemylacetic acids and derivatives therof |
US5843994A (en) * | 1991-10-21 | 1998-12-01 | The United States Of America As Represeneted By The Department Of Health And Human Services | Compositions and methods for treating and preventing pathologies including cancer |
US5852056A (en) * | 1991-10-21 | 1998-12-22 | The United States Of America As Represented By The Department Of Health And Human Services | Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
US5877213A (en) * | 1991-10-21 | 1999-03-02 | The United States Of America As Represented By The Department Of Health And Human Services | Compositions and methods for therapy and prevention of cancer, AIDS, and anemia |
US5883124A (en) * | 1991-10-21 | 1999-03-16 | The United States Of America As Represented By The Department Of Health And Human Services | Compositions and methods for treating and preventing pathologies including cancer |
US6037376A (en) * | 1991-10-21 | 2000-03-14 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for therapy of cancer |
Also Published As
Publication number | Publication date |
---|---|
NL7506384A (en) | 1975-12-02 |
ZA753364B (en) | 1976-05-26 |
DE2523108A1 (en) | 1975-12-18 |
MW3275A1 (en) | 1976-09-08 |
FR2272647A1 (en) | 1975-12-26 |
FR2272647B1 (en) | 1978-10-06 |
BE829756A (en) | 1975-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MD1233B1 (en) | Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof | |
ES480114A1 (en) | Imidazolidine derivatives, process for their preparation, intermediates for use in this process, pharmaceutical compositions containing them and the use of the active compounds. | |
KR910018398A (en) | Carbohydrate derivatives containing three saccharide units | |
GB1205957A (en) | Pharmaceutical compositions comprising 1-pnenoxy-2-aminopropanes | |
GB1473795A (en) | Nonapeptide amides having hormonal activity | |
ES8502709A1 (en) | 1-Alkyl-androsta-1,4-diene-3,17-diones, process for their preparation and pharmaceutical compositions containing them. | |
IE42340L (en) | 11,12-secoprostaglandins | |
GB1511645A (en) | Sickle cell anaemia treatment | |
AU544923B2 (en) | Peptides | |
ES446836A1 (en) | Microscope slide | |
WO1987000174A3 (en) | 1-o-phosphono-saccharides, method for the production and utilization thereof | |
ES8106304A1 (en) | 7-Phenyl-quinolizidine derivatives (I), their preparation, pharmaceutical compositions containing them and (I) for use in treating diseases. | |
IE42168L (en) | 1-alpha-hydroxy and alkanoyloxy-steroids | |
GB1274809A (en) | Evomonoside derivatives | |
GB1460872A (en) | Spirane derivatives and their use as perfuming and flavouring agents | |
GB1460163A (en) | Purification of 6,7-methylene steroid lactones | |
JPS5473729A (en) | Novel muramyldipeptide derivative | |
SE7710337L (en) | PROCEDURE FOR THE PREPARATION OF 9,11-HALOGENERATED STEROIDS | |
CA1027561A (en) | Pharmacologically active 1,4-benzodiazepins and process for their preparation | |
HU172143B (en) | Compositions containing benzoxazoline derivatives and process for producing the active agents | |
JPS5772997A (en) | Novel oligomannoside and its preparation | |
GB1504646A (en) | Acyl cyanoguanidines | |
PH13868A (en) | Ferrocene derivatives,their pharmaceutical compositions and method of use | |
GB1405135A (en) | Antileukaemic ansa macrolides | |
ES469426A1 (en) | Thienamycin derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |